Table 3.
OSAS patient characteristics according to the presence of hypertension
| Control (n = 61) | OSAS without HTN (n = 168) | OSAS with HTN (n = 61) | ANOVA p | |
|---|---|---|---|---|
| Age, years | 44.0 ± 15.4 | 48.9 ± 13.0* | 52.4 ± 11.4* | 0.002 |
| Male, n (%) | 33 (54.1) | 115 (68.5) | 45 (73.8) | 0.051 |
| BMI, kg/m2 | 24.2 ± 4.4 | 26.0 ± 3.5* | 26.6 ± 3.1* | 0.001 |
| SBP, mmHg | 123.4 ± 13.7 | 125.7 ± 12.7 | 130.1 ± 13.6* | 0.018 |
| DBP, mmHg | 78.4 ± 10.7 | 78.8 ± 9.0 | 82.4 ± 10.1* | 0.031 |
| Heart rate, /min | 73.3 ± 10.3 | 74.4 ± 9.4 | 72.0 ± 9.2 | 0.177 |
| Diabetes mellitus, n (%) | 4 (6.5) | 9 (5.4) | 7 (11.5) | 0.255 |
| Dyslipidemia, n (%) | 2 (3.3) | 6 (3.6) | 2 (3.3) | 0.993 |
| Smoking, n (%) | 6 (9.8) | 32 (19.0) | 14 (23.0) | 0.120 |
| Total cholesterol, mg/dl | 170.0 ± 38.2 | 186.1 ± 44.9 | 169.0 ± 38.6 | 0.082 |
| TG, mg/dl | 151.2 ± 80.3 | 157.5 ± 110.1 | 174.1 ± 128.3 | 0.716 |
| FBS, mg/dl | 101.5 ± 17.2 | 103.9 ± 33.7 | 109.9 ± 35.9 | 0.513 |
| ESR, mm/hr | 7.8 ± 11.6 | 16.4 ± 19.3 | 12.4 ± 11.2 | 0.095 |
| hs CRP, mg/L | 0.53 ± 1.32 | 1.02 ± 2.10 | 1.07 ± 1.61 | 0.427 |
| PLR | 99.5 ± 42.3 | 121.4 ± 55.5* | 147.9 ± 61.8* | <0.001 |
| PDW, % | 15.9 ± 1.12 | 16.37 ± 0.81* | 16.44 ± 1.13* | 0.002 |
| AHI | 1.91 ± 1.69 | 33.8 ± 30.1* | 58.2 ± 68.3* | <0.001 |
| ESS | 8.65 ± 4.64 | 10.1 ± 5.85* | 12.4 ± 5.40* | 0.009 |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR: heart rate; TG: triglyceride; FBS: fasting blood sugar; ESR, erythrocyte sedimentation rate; hs-CRP, highly sensitive C-reactive protein; PLR, platelet lymphocyte ratio; PDW, platelet volume distribution width; AHI, apnea-hypopnea index; ESS, Epworth sleepiness scale; *p < 0.05 vs. control group